People channel feed – Endpoints News

People channel feed

How to build CAR–M: Carl June protégé and his biotech publish first evidence in Nature Biotechnology

6 years ago

Doing deals in a time of coronavirus: Biotech CEO Bill Haney says 'you focus on the things that make a difference'

6 years ago

GSK quietly reveals just how much cash they used to buy a chunk of the Bay Area's buzziest startup

6 years ago

Bristol Myers CEO Caforio hires a top investment banker from Barclays for his next BD/strategy chief

6 years ago

‘Patient zero’ in Tennessee talks about fear, anxiety, hysteria and countless acts of kindness as the Biogen outbreak spreads

6 years ago

Five days after regaining the helm at CureVac — and 1 day after controversy erupted — Ingmar Hoerr makes surprise exit

6 years ago

Biogen staffer fled to China in search of emergency Covid-19 testing, care — and now faces criminal charges

6 years ago

Biotech entrepreneurs Arie Belldegrun and Cedric Francois test positive for Covid-19 — and here's why they want you to know

6 years ago

Vir’s George Scangos teams up with his former colleagues at Biogen to press fast-forward on antibody programs for coronavirus

6 years ago

After a year of big advances, AstraZeneca CEO Pascal Soriot takes home a major-league pay package

6 years ago

Stanford stem cell pioneer nets $194M from Gilead-Forty Seven buyout

6 years ago

Versant woos MorphoSys' ex-CSO to its booming discovery engine, with big plans for new startups

6 years ago

Nine new coronavirus cases are tied to the Biogen outbreak — as infections spread to 'close contacts'

6 years ago

MacroGenics loses CMO Jon Wigginton as commercialization looms

6 years ago

After a trendsetting role in global biotech venture investing, David Mott parts ways with NEA

6 years ago

GSK's Emma Walmsley awarded £8.4M pay package after £2.5M rise, finally catching up with fellow pharma CEOs

6 years ago

AMAG CMO hits the exit just as biotech searches for new CEO to right a ship rocked by Makena controversy

6 years ago

Vertex, Seattle Genetics, Alpine withdraw from investor conference as biotechs brace for coronavirus

6 years ago

As US dials up coronavirus response, BIO taps Vir's George Scangos to head committee coordinating industry efforts

6 years ago

Scoop: Corporate development chief hits the exit at Biogen as aducanumab jitters roll on

6 years ago

Turning focus to clinical work, Verastem axes 31 jobs, scales back cancer drug promotion after disappointing sales

6 years ago

Ex-Sanofi chief Olivier Brandicourt, current Blackstone advisor, jumps on Alnylam board

6 years ago

Spark loses another top exec in the wake of $4.3B takeover by Roche — report

6 years ago

Gene therapy pioneer Kathy High has left Spark after completing $4.3B union with Roche

6 years ago

First page Previous page 69 70 717273 74 75 Next page Last page